GLAXO - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 3.6
| Stock Code | GLAXO | Market Cap | 39,580 Cr. | Current Price | 2,336 ₹ | High / Low | 3,516 ₹ |
| Stock P/E | 39.8 | Book Value | 101 ₹ | Dividend Yield | 1.80 % | ROCE | 62.6 % |
| ROE | 46.4 % | Face Value | 10.0 ₹ | DMA 50 | 2,429 ₹ | DMA 200 | 2,554 ₹ |
| Chg in FII Hold | -0.01 % | Chg in DII Hold | -0.02 % | PAT Qtr | 277 Cr. | PAT Prev Qtr | 253 Cr. |
| RSI | 39.9 | MACD | -3.67 | Volume | 1,17,290 | Avg Vol 1Wk | 1,20,292 |
| Low price | 2,218 ₹ | High price | 3,516 ₹ | PEG Ratio | -2.01 | Debt to equity | 0.02 |
| 52w Index | 9.15 % | Qtr Profit Var | 21.3 % | EPS | 58.8 ₹ | Industry PE | 30.1 |
📈 Chart & Trend: GLAXO is trading below both its 50 DMA (2,429 ₹) and 200 DMA (2,554 ₹), signaling weakness. RSI at 39.9 indicates oversold conditions, while MACD at -3.67 confirms bearish undertones. Bollinger Bands show price near the lower band, suggesting downside pressure but also potential for a technical rebound.
🔎 Momentum Signals: Current volume (1.17 lakh) is slightly below the 1-week average (1.20 lakh), reflecting muted participation. Short-term reversal attempts may occur if RSI stabilizes, but trend remains weak.
🎯 Entry Zone: 2,300–2,350 ₹ (support near recent low)
🚪 Exit Zone: 2,700–2,800 ₹ (resistance near 200 DMA)
📊 Trend Status: Reversing from downtrend; oversold but weak momentum.
Positive
- Exceptional ROCE (62.6%) and ROE (46.4%) highlight strong profitability.
- Quarterly PAT rose to 277 Cr. from 253 Cr., showing earnings growth.
- Dividend yield at 1.80% provides steady returns.
- Low debt-to-equity (0.02) ensures financial stability.
Limitation
- Stock P/E (39.8) is above industry average (30.1), indicating premium valuation.
- PEG ratio (-2.01) reflects weak growth prospects.
- Book value (101 ₹) is low relative to current price, limiting intrinsic support.
- 52-week performance at 9.15% lags sector peers significantly.
Company Negative News
- Decline in institutional holdings (FII -0.01%, DII -0.02%) signals reduced investor confidence.
Company Positive News
- Strong quarterly profit growth (+21.3%).
- Operational efficiency remains high with industry-leading ROCE and ROE.
Industry
- Industry P/E at 30.1 reflects moderate valuations across pharma sector.
- Sector supported by demand for specialty drugs and healthcare expansion.
Conclusion
GLAXO is currently weak, trading below key moving averages with bearish momentum. Entry near 2,300–2,350 ₹ offers cautious accumulation, while profit booking is advised near 2,700–2,800 ₹. Short-term outlook remains bearish, but strong fundamentals and profitability provide long-term resilience if growth stabilizes.
This HTML report is structured for direct integration into your trading workflow. Would you like me to extend this into a multi-horizon overlay (intraday, swing, and investment perspectives) for GLAXO to capture different trading strategies?